The 36-month beta value for MRUS is at 1.09. Analysts have varying views on the stock, with 12 analysts rating it as a “buy,” 4 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for MRUS is 58.58M, and currently, shorts hold a 14.78% of that float. The average trading volume for MRUS on November 21, 2024 was 480.57K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MRUS) stock’s latest price update
Merus N.V (NASDAQ: MRUS)’s stock price has plunge by 2.10relation to previous closing price of 42.93. Nevertheless, the company has seen a -11.73% plunge in its stock price over the last five trading sessions. schaeffersresearch.com reported 2024-11-21 that Biotech stock Merus NV (NASDAQ:MRUS) is up 3.4% at $44.40 at last glance, though pulling back a bit from its premarket surge, after Goldman Sachs initiated coverage with a “buy” rating.
MRUS’s Market Performance
Merus N.V (MRUS) has seen a -11.73% fall in stock performance for the week, with a -16.21% decline in the past month and a -18.21% plunge in the past quarter. The volatility ratio for the week is 5.63%, and the volatility levels for the past 30 days are at 4.25% for MRUS. The simple moving average for the past 20 days is -12.40% for MRUS’s stock, with a -11.73% simple moving average for the past 200 days.
Analysts’ Opinion of MRUS
UBS, on the other hand, stated in their research note that they expect to see MRUS reach a price target of $72. The rating they have provided for MRUS stocks is “Buy” according to the report published on October 24th, 2024.
Truist gave a rating of “Buy” to MRUS, setting the target price at $69 in the report published on March 28th of the current year.
MRUS Trading at -13.15% from the 50-Day Moving Average
After a stumble in the market that brought MRUS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.85% of loss for the given period.
Volatility was left at 4.25%, however, over the last 30 days, the volatility rate increased by 5.63%, as shares sank -16.20% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.81% lower at present.
During the last 5 trading sessions, MRUS fell by -11.74%, which changed the moving average for the period of 200-days by +15.16% in comparison to the 20-day moving average, which settled at $50.03. In addition, Merus N.V saw 59.39% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MRUS starting from Shuman Harry, who sale 2,500 shares at the price of $54.00 back on Aug 21 ’24. After this action, Shuman Harry now owns 7,002 shares of Merus N.V, valued at $135,000 using the latest closing price.
Shuman Harry, the VP Controller, PAO of Merus N.V, sale 2,500 shares at $54.00 during a trade that took place back on Aug 20 ’24, which means that Shuman Harry is holding 7,002 shares at $135,000 based on the most recent closing price.
Stock Fundamentals for MRUS
Current profitability levels for the company are sitting at:
- -6.43 for the present operating margin
- -0.04 for the gross margin
The net margin for Merus N.V stands at -6.81. The total capital return value is set at -0.3. Equity return is now at value -44.60, with -36.59 for asset returns.
Based on Merus N.V (MRUS), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -87.44. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -18.45.
Currently, EBITDA for the company is -149.21 million with net debt to EBITDA at 1.73. When we switch over and look at the enterprise to sales, we see a ratio of 71.28. The receivables turnover for the company is 9.25for trailing twelve months and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.32.
Conclusion
In conclusion, Merus N.V (MRUS) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
